TipRanks
Hana Pharm Co., Ltd. (KR:293480)
:293480
South Korea Market
293480
Hana Pharm Co., Ltd.
RESEARCH TOOLSreports

Hana Pharm Co., Ltd. (293480) Income Statement

― Followers

Hana Pharm Co., Ltd. Income Statement

Last quarter (Q2 2026), Hana Pharm Co., Ltd.'s total revenue was ₩60.90B, an increase of 5.23% from the same quarter last year. In Q2, Hana Pharm Co., Ltd.'s net income was ₩8.45B. See Hana Pharm Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₩ 239.50B₩ 225.34B₩ 224.46B₩ 210.84B₩ 196.41B
Gross Profit
₩ 146.39B₩ 141.29B₩ 139.58B₩ 131.24B₩ 130.82B
Operating Expenses
₩ 120.47B₩ 116.14B₩ 112.55B₩ 100.07B₩ 94.81B
Depreciation and Amortization
₩ 11.03B₩ 7.72B₩ 7.65B₩ 6.49B₩ 5.76B
EBITDA
₩ 36.95B₩ 32.87B₩ 34.68B₩ 37.80B₩ 41.65B
Operating Income
₩ 25.92B₩ 25.15B₩ 27.03B₩ 31.17B₩ 36.01B
Other Income/Expenses
₩ -7.56B₩ 239.91M₩ 875.51M₩ -452.40M₩ -163.21M
Pretax Income
₩ 18.38B₩ 25.39B₩ 27.91B₩ 30.72B₩ 35.85B
Net Income
₩ 8.78B₩ 21.25B₩ 22.33B₩ 24.31B₩ 28.01B
Per Share Metrics
Basic EPS
₩ 507.00₩ 1.23K₩ 1.29K₩ 1.41K₩ 1.68K
Diluted EPS
₩ 507.00₩ 1.23K₩ 1.29K₩ 1.41K₩ 1.68K
Weighted Average Shares Outstanding
 17.77M 17.30M 17.30M 17.30M 16.68M
Weighted Average Shares Outstanding (Diluted)
 17.77M 17.30M 17.30M 17.30M 16.68M
Currency in KRW

Hana Pharm Co., Ltd. Earnings and Revenue History